Combined high-dose rate brachytherapy (HDR-BT) and whole pelvic radiation therapy (WPRT) in node negative, intermediate- to high-risk localised prostate cancer: clinical outcomes and patient behaviours across ethnicities

Publisher： Cambridge University Press

E-ISSN： 1467-1131|16|2|141-147

ISSN： 1460-3969

Source： Journal of Radiotherapy in Practice, Vol.16, Iss.2, 2017-05, pp. : 141-147

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Conformal radiotherapy plus high dose rate brachytherapy prostate boost in patients with intermediate and high risk prostate cancer: our experience in Asian males

By  

Journal of Radiotherapy in Practice, Vol. 11, Iss. 4, 2012-05 ,pp. : 257-270

Cambridge University Press

Access to resources Recommend Favorite

Therapeutic outcomes of neoadjuvant and concurrent androgen‐deprivation therapy and intensity‐modulated radiation therapy with gold marker implantation for intermediate‐risk and high‐risk prostate cancer

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 5, 2015-05 ,pp. : 477-482

John Wiley & Sons Inc

Access to resources Recommend Favorite

Preliminary patient‐reported outcomes analysis of 3‐dimensional radiation therapy versus intensity‐modulated radiation therapy on the high‐dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial

By  

CANCER, Vol. 121, Iss. 14, 2015-07 ,pp. : 2422-2430

John Wiley & Sons Inc

Access to resources Recommend Favorite

Needle Displacement during High-Dose-Rate Afterloading Brachytherapy Boost and Conventional External Beam Radiation Therapy for Initial and Local Advanced Prostate Cancer

By  

Urologia Internationalis, Vol. 70, Iss. 3, 2003-04 ,pp. : 200-204

Karger

Access to resources Recommend Favorite

Editorial Comment to Therapeutic outcomes of neoadjuvant and concurrent androgen‐deprivation therapy and intensity‐modulated radiation therapy with gold marker implantation for intermediate and high‐risk prostate cancer

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 5, 2015-05 ,pp. : 482-483

John Wiley & Sons Inc

Access to resources Recommend Favorite